Comparative analysis of PG-DTR and TG-RY shows similar outcomes in early-stage proximal gastric cancer, indicating viable options.
Key Points
PG-DTR improved postoperative nutritional status, including better body weight and albumin levels, compared to TG-RY.
Overall survival (OS) and disease-free survival (DFS) showed no significant differences between PG-DTR and TG-RY groups after propensity score matching.
Fewer retrieved lymph nodes were found in the PG-DTR group than in the TG-RY group, without impacting short-term surgical outcomes.
Quality of life was comparable in both groups, but the TG-RY group experienced greater weight loss postoperatively.